Experience

Davis Polk is advising VF Corporation on its $820 million acquisition of Williamson-Dickies Holding Company. The transaction, which is expected to close early in the fourth quarter of 2017,…

Davis Polk is advising PharMerica Corporation on its approximately $1.4 billion acquisition by a newly formed company controlled by KKR, with Walgreens Boots Alliance, Inc. as a minority…

Davis Polk advised the initial purchasers on a Rule 144A and Regulation S offering of $250 million aggregate principal amount of 9.750% senior notes due 2022 of Credivalores…

Davis Polk is advising Noble Group Limited on the sale of its wholly-owned subsidiary Noble Americas Gas & Power Corp. to Mercuria Energy America, Inc. The transaction, which is…

Davis Polk is advising Reckitt Benckiser Group plc on the sale of its Food Division to McCormick & Company Inc. for $4.2 billion in cash, subject to typical purchase price adjustments…

Davis Polk is advising Bertelsmann SE & Co. KGaA on its acquisition of a 22% stake in Penguin Random House from co-owner Pearson plc. The acquisition will give Bertelsmann a 75% stake…

Davis Polk advised the joint bookrunners in connection with a primary offering by BR Properties S.A. of common shares for an aggregate amount of R$953 million (approximately US$288 million)…

Davis Polk advised China Reinsurance (Group) Corporation (“China Re”) in connection with its $700 million tap offering of notes by its subsidiary, China Reinsurance Finance Corporation…

Davis Polk advised the joint book-running managers in connection with the $86.3 million initial public offering of common stock of Dova Pharmaceuticals, Inc. The common stock is listed on…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $75 million initial public offering of common stock of Mersana Therapeutics…